Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant.
Khan QJ, Bivona CR, Martin GA, Zhang J, Liu B, He J, Li KH, Nelson M, Williamson S, Doolittle GC, Sun W, Mudaranthakam DP, Streeter NR, McGuirk JP, Al-Rajabi R, Hoffmann M, Kasi A, Parikh RA, Zhong C, Mitchell L, Pessetto ZY, Pathak H, Ghosh A, LaFaver S, Sharma P, Godwin AK.
Khan QJ, et al. Among authors: he j.
JAMA Oncol. 2022 Jul 1;8(7):1053-1058. doi: 10.1001/jamaoncol.2022.0752.
JAMA Oncol. 2022.
PMID: 35446353
Free PMC article.